Sort
261,768 grants matching “gene therapy”
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study
$2,684,971Jeffrey Samuel Hyams · Connecticut Children'S Medical Center · U01 · FY2012 · DK
Plasma Cells in Health and Disease
$2,684,918Ignacio E. Sanz · Emory University · P01 · FY2025 · AI
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication
$2,683,351Li Tang · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,682,681Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
NIH-Owned Chimpanzee Research Resource at the SNPRC
$2,681,884John L Vandeberg · Texas Biomedical Research Institute · U42 · FY2012 · OD
Comprehensively Defining the Novel Alphaviral Capsid Protein / IRAK1 Interaction
$2,681,840Kevin Joseph Sokoloski · University Of Louisville · R01 · FY2025 · AI
SPORE IN PROSTATE CANCER
$2,680,997William George Nelson · Johns Hopkins University · P50 · FY2006 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,680,780Robert S Negrin · Stanford University · P01 · FY2022 · CA
Investigations of Methylmalonic Acidemia and Related Disorders
$2,679,986Charles P Venditti · National Human Genome Research Institute · ZIA · FY2023 · HG
The Inflammatory Index as a Biomarker for Pain in Patients with Sickle Cell Disease
$2,679,842Amanda M Brandow · Medical College Of Wisconsin · R61 · FY2019 · NS
The multifaceted role of acetate in cancer
$2,679,000Zachary T Schug · Wistar Institute · DP2 · FY2019 · CA
General Clinical Research Center
$2,678,470Ralph David Feigin · Baylor College Of Medicine · M01 · FY2007 · RR
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
$2,678,459Devanand Sarkar · Virginia Commonwealth University · P01 · FY2024 · CA
Precision Delivery and Imaging to Enhance Solid Tumor Therapy
$2,678,066Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2021 · CA
Models and Gene Therapies for AAT Deficiency
$2,676,698Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2022 · HL
Presenilin and APP in the Brain
$2,675,675Jie Shen · Brigham And Women'S Hospital · RF1 · FY2021 · NS
UCLA Center for AIDS Research (CFAR)
$2,675,166Jerome A. Zack · University Of California Los Angeles · P30 · FY2010 · AI
Models and Gene Therapies for AAT Deficiency
$2,673,457Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT
$2,673,360Brigham And Women'S Hospital · U01 · FY2002 · HL
GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE
$2,672,209Stanford University · U01 · FY2002 · HL
Cell and Gene Therapy for Nonmalignant Blood Disorders
$2,670,915Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2015 · HL
SPORE in Breast Cancer
$2,670,894University Of North Carolina Chapel Hill · P50 · FY2005 · CA
Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant
$2,670,621Colleen Delaney · Fred Hutchinson Cancer Research Center · P50 · FY2012 · HL
SPORE in Breast Cancer
$2,670,618University Of North Carolina Chapel Hill · P50 · FY2004 · CA
Integrated Nanosystems for Diagnosis and Therapy
$2,668,778Karen L. Wooley · Washington University · U01 · FY2009 · HL